In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Medyssey

'Constantly Being Chased': Cutting-Edge Gene Therapy Developers Moving Fast In China

Plagued by a scandal which gained global attention a few years go, the gene therapy sector has recovered and is now thriving in China. But a drive for innovation, combined with ready cash for aspiring start-ups, may not translate into leaps and bounds in the field due to challenges unique to these latest treatments, including manufacturing, durability and coverage.

China Gene Therapy

China Gene Therapy Developers Rush To Clinic In 'Winner Takes All' Battle

Gene therapies for conditions ranging from hemophilia to retinal diseases are blossoming in China and the race in which the winner may take all is on. Driven by ready investors, the field is on the cusp of becoming the latest innovation battleground in the country, while some developers are already moving ahead in the US.

Gene Therapy Innovation

China Gene Therapy Developers Rush To Clinic In 'Winner Takes All' Battle

Gene therapies for conditions ranging from hemophilia to retinal diseases are blossoming in China and the race in which the winner may take all is on. Driven by ready investors, the field is on the cusp of becoming the latest innovation battleground in the country, while some developers are already moving ahead in the US.

China Gene Therapy

Illumina, Varian Among Flurry Of China Collabs

The ever-growing importance of the Chinese market and the increasing presence of Chinese players in the global medtech arena has not gone amiss in 2017, and the new year began with a flurry of announcements of further East-West partnerships being forged, including one by next-gen sequencing leader Illumina and by cancer therapy specialist Varian Medical Systems. Additionally, global investment firm Ally Bridge sealed a deal with LifeTech to co-invest in medtech companies looking to tackle China.

China Cancer
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Medical Devices
    • Implantable Devices
  • Other Names / Subsidiaries
    • Varian Co., Ltd
UsernamePublicRestriction

Register